Cargando…
Botulinum toxin antibody titres: measurement, interpretation, and practical recommendations
Botulinum toxin (BT) therapy may be blocked by antibodies (BT-AB) resulting in BT-AB induced therapy failure (ABF). BT-AB may be detected by the mouse lethality assay (MLA), the mouse diaphragm assay (MDA) and the sternocleidomastoid test (SCMT). For the first time, we wanted to compare all three BT...
Autores principales: | Dressler, Dirk, Rothwell, John C., Bhatia, Kailash, Kopp, Bruno, Bigalke, Hans, Adib Saberi, Fereshte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971068/ https://www.ncbi.nlm.nih.gov/pubmed/36434127 http://dx.doi.org/10.1007/s00415-022-11424-0 |
Ejemplares similares
-
Botulinum toxin dosing in arm muscles: contextual factors
por: Dressler, Dirk, et al.
Publicado: (2021) -
Economics of botulinum toxin therapy: influence of the abobotulinumtoxinA package size on the costs of botulinum toxin therapy
por: Dressler, Dirk, et al.
Publicado: (2017) -
Botulinum toxin therapy of dystonia
por: Dressler, Dirk, et al.
Publicado: (2020) -
Botulinum toxin therapy in the SARS-CoV-2 pandemic: patient perceptions from a German cohort
por: Dressler, Dirk, et al.
Publicado: (2020) -
Botulinum toxin therapy of cervical dystonia: comparing onabotulinumtoxinA (Botox(®)) and incobotulinumtoxinA (Xeomin(®))
por: Dressler, Dirk, et al.
Publicado: (2013)